FR2636948B1 - N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant - Google Patents

N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant

Info

Publication number
FR2636948B1
FR2636948B1 FR898912527A FR8912527A FR2636948B1 FR 2636948 B1 FR2636948 B1 FR 2636948B1 FR 898912527 A FR898912527 A FR 898912527A FR 8912527 A FR8912527 A FR 8912527A FR 2636948 B1 FR2636948 B1 FR 2636948B1
Authority
FR
France
Prior art keywords
piperidylmethyl
benzamides
antiarrhythmic
substituted
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR898912527A
Other languages
English (en)
Other versions
FR2636948A1 (fr
Inventor
Elden H Banitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riker Laboratories Inc
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of FR2636948A1 publication Critical patent/FR2636948A1/fr
Application granted granted Critical
Publication of FR2636948B1 publication Critical patent/FR2636948B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR898912527A 1988-09-26 1989-09-25 N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant Expired - Fee Related FR2636948B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/248,814 US4952574A (en) 1988-09-26 1988-09-26 Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides

Publications (2)

Publication Number Publication Date
FR2636948A1 FR2636948A1 (fr) 1990-03-30
FR2636948B1 true FR2636948B1 (fr) 1994-09-30

Family

ID=22940797

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898912527A Expired - Fee Related FR2636948B1 (fr) 1988-09-26 1989-09-25 N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant

Country Status (3)

Country Link
US (1) US4952574A (fr)
DE (1) DE3931954A1 (fr)
FR (1) FR2636948B1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316627B1 (en) * 1997-04-21 2001-11-13 Fine Tech Ltd. Process for the preparation of flecainide
DE19982965B3 (de) * 1998-12-25 2012-08-30 Jnc Corporation Flüssigkristalline Verbindung mit einem negativen Wert der dielektrischen Anisotropie
DE10025700A1 (de) * 2000-05-26 2001-11-29 Merck Patent Gmbh Verfahren zur Herstellung von trifluorethoxysubstituierten Benzoesäuren
US20040220409A1 (en) * 2001-02-20 2004-11-04 Mcdaniel William C Flecainide synthesis
MXPA05008088A (es) * 2003-02-24 2005-09-21 Mallinckrodt Inc Proceso mejorado para preparar benzhidril tioacetamida.
WO2007054785A1 (fr) * 2005-11-08 2007-05-18 Atheris Laboratories Peptides de type mu-conotoxine et leur emploi en tant qu'anesthésique local
AP2014007805A0 (en) 2011-12-28 2014-07-31 Cytokinetics Inc The Regents Of The University Of California Substituted benzaldehyde compounds and methods fortheir use in increasing tissue oxygenation
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
MX2015011769A (es) 2013-03-15 2016-06-02 Global Blood Therapeutics Inc Compuestos y sus usos para modular la hemoglobina.
EP2970308B1 (fr) 2013-03-15 2021-07-14 Global Blood Therapeutics, Inc. Composés et leurs utilisations pour la modulation de l'hémoglobine
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
SG10201802911RA (en) 2013-03-15 2018-05-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
PT3102208T (pt) 2014-02-07 2021-04-05 Global Blood Therapeutics Inc Polimorfos cristalinos da base livre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3 il)metoxi)benzaldeído
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
BR112018011272A2 (pt) 2015-12-04 2018-11-21 Global Blood Therapeutics Inc regimes de dosagem para 2-hidróxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metóxi)benzaldeído
TWI752307B (zh) 2016-05-12 2022-01-11 美商全球血液治療公司 新穎化合物及製造化合物之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (fr) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulateurs de l'hémoglobine pour le traitement de la drépanocytose

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US4013670A (en) * 1974-04-01 1977-03-22 Riker Laboratories, Inc. Derivatives of pyrrolidine and piperidine
US3900481A (en) * 1974-04-01 1975-08-19 Riker Laboratories Inc Derivatives of pyrrolidine and piperidine
US4005209A (en) * 1974-04-01 1977-01-25 Riker Laboratories, Inc. Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides
US4097481A (en) * 1976-11-08 1978-06-27 Riker Laboratories, Inc. Tertiary amide derivatives of pyrrolidine and piperidine
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
US4650873A (en) * 1979-03-19 1987-03-17 Riker Laboratories Process for the preparation of a derivative of piperidine
US4452983A (en) * 1981-06-08 1984-06-05 Riker Laboratories, Inc. Phenolic derivative
US4339587A (en) * 1981-06-08 1982-07-13 Riker Laboratories, Inc. 5-Benzyloxy or 5-hydroxy-2-(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide
IT1171707B (it) * 1983-09-30 1987-06-10 Babcock Samifi Spa Dispositivo per il raffreddamento dell'olio in una unita' di compressione e, particolarmente, di compressione a vite
US4599434A (en) * 1983-11-15 1986-07-08 Riker Laboratories, Inc. Cyclopentanone derivatives
US4656285A (en) * 1983-11-15 1987-04-07 Riker Laboratories, Inc. Compound 2-acetamidomethyl-6-methoxy-pyridine

Also Published As

Publication number Publication date
US4952574A (en) 1990-08-28
DE3931954A1 (de) 1990-03-29
FR2636948A1 (fr) 1990-03-30

Similar Documents

Publication Publication Date Title
FR2636948B1 (fr) N-(2-piperidylmethyl)benzamides substitues anti-arythmiques et composition pharmaceutique les contenant
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2604357B1 (fr) Composition pharmaceutique et cosmetique anti-acneique
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
PT84737B (pt) Processo para a preparacao de derivados de n-(2'-aminofenil)-benzamida e de composicoes farmaceuticas contendo-os
DK330287D0 (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
NZ222977A (en) Aminotetralins and pharmaceutical compositions; 8-substituted-2-aminotetralins and pharmaceutical compositions thereof
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
FR2645152B1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
FR2601875B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol
FR2596651B1 (fr) Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
IL78939A0 (en) N-substituted arylalkyl-and arylalkylene-aminoheterocyclics and pharmaceutical compositions containing them
PT87470A (pt) Process for the preparation of novel substituted benzamides and of pharmaceutical compositions containing the same
BE876042A (fr) Nouvelles 4-(quinoleinylaminobenzoyl) piperidines et composition pharmaceutique les contenant
FR2626175B1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
FR2488135B1 (fr) Composition pharmaceutique a base de propylene-glycol et d'acetaminophene
FR2638640B1 (fr) Solution pharmaceutique
FR2636946B1 (fr) ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
MC1847A1 (fr) Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant
FR2352790A1 (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
FR2598617B1 (fr) Composition pharmaceutique
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
ST Notification of lapse